ERBB2 and breast carcinoma: Among the 16 patients, six were hormone receptor (Estrogen receptor [ER] and/or Progesterone receptor [PgR]) positive and seven were human epidermal growth factor receptor 2 (HER2) positive as assessed immunohistochemistry in Primary breast cancers.